FMAU (2 mg)

4-(4’-Flouoroanilino)-6,7-dimethoxyquinazoline hydrochloride

Product No.：SFPD-95

CAS No.：not yet assigned

Note

• Care must be taken when handling this product.
• Do not contact skin or eyes.
• Do not ingest or inhale.
• Store at <-20℃. Protect from light.(Short-term storage (<1 month) at higher temperatures (e.g. during transport) does not affect product quality)
• It shall be only used by qualified personnel.

Order Number

• SFPD-95-0010x       10mg per vial 
• SFPD-95-0020x       20mg per vial
  • note: x includes A B C and D, A refers to 2ml vial; B refers to 4.5ml vial; C refers to 8ml vial; D refers to 30ml vial 
  • *Customized dispensing is available

Literature

• Manrner T.J. et al. Synthesis of 2’-deoxy-2’-[¹⁸F]fluoro-beta-D-arabinofuranosyl nucleosides, [¹8F]FAU, [¹⁸F]FMAU, [¹⁸F]FBAU, [¹⁸F]FIAU, as potential PET agents for imaging cellular proliferation. Nucl. Med. Biol. 2003, 30,215-224.
• Alauddin M.M. et al. Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer model. Mol. Imaging 2004, 3, 76-84.
• Alauddin M.M. et al. Synthesis and evaluation of 2’-deoxy-2’-18F-fluoro-5-fluoro-1-beta-D-arabinofuranosyluracil as a potential PET imaging agent for suicide gene expression. J. Nucl. Med. 2004, 45, 2063-2069